TREX1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.458000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.445800E-02
Normal-vs-Stage2
2.792200E-02
Normal-vs-Stage3
1.393600E-01
Normal-vs-Stage4
2.639000E-01
Stage1-vs-Stage2
7.800200E-01
Stage1-vs-Stage3
7.845200E-01
Stage1-vs-Stage4
7.840600E-01
Stage2-vs-Stage3
5.903400E-01
Stage2-vs-Stage4
9.053000E-01
Stage3-vs-Stage4
6.950000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.236160E-02
Normal-vs-AfricanAmerican
1.711420E-01
Normal-vs-Asian
7.527400E-01
Caucasian-vs-AfricanAmerican
6.271700E-02
Caucasian-vs-Asian
9.631600E-02
AfricanAmerican-vs-Asian
3.609900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.448000E-02
Normal-vs-Female
1.243700E-02
Male-vs-Female
9.860600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.302390E-01
Normal-vs-Age(41-60Yrs)
2.531900E-02
Normal-vs-Age(61-80Yrs)
4.106400E-02
Normal-vs-Age(81-100Yrs)
2.202000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.893400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.973200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.046000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.071400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.006600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.241800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.388020E-02
Normal-vs-Daily Drinker
4.517800E-01
Normal-vs-Weekly Drinker
7.395600E-02
Normal-vs-Occasional Drinker
9.486000E-02
Normal-vs-Social Drinker
8.584100E-03
Non Drinker-vs-Daily Drinker
7.671700E-02
Non Drinker-vs-Weekly Drinker
4.661800E-01
Non Drinker-vs-Occasional Drinker
1.973600E-01
Non Drinker-vs-Social Drinker
6.229000E-01
Daily Drinker-vs-Weekly Drinker
2.651000E-01
Daily Drinker-vs-Occasional Drinker
4.072800E-01
Daily Drinker-vs-Social Drinker
4.278300E-02
Weekly Drinker-vs-Occasional Drinker
6.815000E-01
Weekly Drinker-vs-Social Drinker
2.773800E-01
Occasional Drinker-vs-Social Drinker
1.147190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.799600E-01
Normal-vs-Grade 2
7.950400E-01
Normal-vs-Grade 3
9.670000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.351220E-01
Grade 1-vs-Grade 3
8.301600E-01
Grade 1-vs-Grade 4
8.799600E-01
Grade 2-vs-Grade 3
6.414000E-02
Grade 2-vs-Grade 4
7.950400E-01
Grade 3-vs-Grade 4
9.670000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.437570E-01
Normal-vs-NonDiabetic
1.567870E-02
Diabetic-vs-NonDiabetic
9.930600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.977620E-01
Normal-vs-NoPancreatitis
2.806300E-02
Pancreatitis-vs-NoPancreatitis
4.086400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.134160E-01
Normal-vs-N1
9.877000E-03
N0-vs-N1
1.140030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.234020E-01
Normal-vs-TP53-NonMutant
1.971540E-02
TP53-Mutant-vs-TP53-NonMutant
3.262400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
